We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Markers Predicting Obesity Can Be Detected In Urine

By LabMedica International staff writers
Posted on 10 May 2015
Print article
Image: Proton (1H) nuclear magnetic resonance (NMR) spectroscopy apparatus (Photo courtesy of Imperial College London).
Image: Proton (1H) nuclear magnetic resonance (NMR) spectroscopy apparatus (Photo courtesy of Imperial College London).
The prevalence of obesity and being overweight is rising worldwide, and there is a need to understand the relationship of obesity to increased risk of death from heart disease, stroke, diabetes, and cancer.

Chemical markers have been identified in urine that are associated with body mass and this discovery may provide new insights into how obesity leads to disease as it is estimated that obesity-driven disease results in 3.4 million deaths per year worldwide.

An international team of scientists led by those at Imperial College London (UK) analyzed urine samples from over 2,000 volunteers in the US and UK. Metabolic profiling of urine samples collected over two 24-hour time periods three weeks apart showed reproducible patterns of metabolite excretion associated with adiposity. The team used 24-hour urinary metabolic profiling by proton (1H) nuclear magnetic resonance (NMR) spectroscopy and ion exchange chromatography.

Exploratory analysis of the urinary metabolome using 1H NMR spectroscopy (Bruker; Coventry, UK) of the 1,800 US samples identified 29 molecular species, clustered in interconnecting metabolic pathways that were significantly associated with body mass index (BMI); 25 of these species were also found in the 444 samples in the UK validation cohort.

The investigators found multiple associations between urinary metabolites and BMI including urinary glycoproteins and N-acetyl neuraminate (related to renal function), trimethylamine, dimethylamine, 4-cresyl sulfate, phenylacetylglutamine and 2-hydroxyisobutyrate (gut microbial co-metabolites), succinate and citrate (tricarboxylic acid cycle intermediates), ketoleucine and the ketoleucine/leucine ratio (linked to skeletal muscle mitochondria) and branched-chain amino acid metabolism), ethanolamine (skeletal muscle turnover), and 3-methylhistidine (skeletal muscle turnover and meat intake).

Jeremy K. Nicholson, PhD, a professor and senior author of the study, said, “Obesity has become a huge problem all over the world, threatening to overwhelm health services and drive life expectancy gains into reverse. Tackling it is an urgent priority and it requires us to have a much better understanding of how body fat and other aspects of biology are related. These findings provide possible starting points for new approaches to preventing and treating obesity and its associated diseases.” The study was published on April 29, 2015, in the journal Science Translational Medicine.

Related Links:

Imperial College London
Bruker 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more